beta
Trial Radar IA
Lo studio clinico NCT07255131 (RAKITZIHCFA) per Depression - Major Depressive Disorder, Anxiety Chronic, Ansia, Esito funzionale, Recupero, Obsessive Compulsive Disorders, Assertiveness è in arruolamento. Consulti la vista a schede del Radar degli Studi Clinici e gli strumenti di scoperta IA per tutti i dettagli. Oppure, ponga pure una domanda qui.
Un studio corrisponde ai criteri del filtro
Vista a schede

The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program (RAKITZIHCFA)

In arruolamento
I dettagli dello studio clinico sono disponibili principalmente in inglese. Tuttavia, Trial Radar IA può essere d'aiuto! Basta cliccare su 'Spiega lo studio' per visualizzare e discutere le informazioni sullo studio nella lingua selezionata.
La sperimentazione clinica NCT07255131 (RAKITZIHCFA) è uno studio interventistico per Depression - Major Depressive Disorder, Anxiety Chronic, Ansia, Esito funzionale, Recupero, Obsessive Compulsive Disorders, Assertiveness, attualmente in arruolamento. Avviato il 26 settembre 2025, prevede di arruolare 52 partecipanti. Sotto la guida di Rakitzi, Stavroula, dovrebbe concludersi entro il 20 dicembre 2028. I dati più recenti da ClinicalTrials.gov sono stati aggiornati l'ultima volta il 28 novembre 2025.
Sommario breve
An online group cognitive behavioral psychotherapeutic program will be offered to patients with cystic fibrosis and to caregivers by the Hellenic Cystic Fibrosis Association. These 2 above therapy groups will be compared with control groups in a randomized controlled trial
Descrizione dettagliata
A therapy group of patients with cystic fibrosis, who participate on the online group cognitive behavioral psychotherapeutic program will be compared with a control group of patients with cystic fibrosis, who participate in an online group supportive psychotherapeutic program. Both of the groups participate on 13 sessions once a week.

A therapy group of caregivers, who participate on the online group cognitive behavioral psychotherapeutic program will be compared with a control group of caregivers, who participate in an online group supportive psychotherapeutic program. Both of the groups participate on 13 sessions once a week.

Titolo ufficiale

The Effectiveness and Efficacy of an Online Group Cognitive Behavioral Psychotherapy in Patients With Cystic Fibrosis and Caregivers in Comparison to Control Groups by the Hellenic Cystic Fibrosis Association A Randomized Controlled Trial

Condizioni
Depression - Major Depressive DisorderAnxiety ChronicAnsiaEsito funzionaleRecuperoObsessive Compulsive DisordersAssertiveness
Pubblicazioni
Articoli scientifici e documenti di ricerca pubblicati su questo studio clinico:
Altri ID dello studio
  • RAKITZIHCFA
  • RAKITZI CYSTIC FIBROSIS
  • HELLENIC CYSTIC FIBROSIS ASSOC (Altro identificativo) (HELLENIC CYSTIC FIBROSIS ASSOCIATION & DR. STAVROULA RAKITZI)
Numero NCT
Data di inizio (effettiva)
2025-09-26
Ultimo aggiornamento pubblicato
2025-11-28
Data di completamento (stimata)
2028-12-20
Arruolamento (previsto)
52
Tipo di studio
Interventistico
FASE
N.D.
Stato
In arruolamento
Parole chiave
Cystic Fibrosis
Group cognitive behavioral psychotherapy
Scopo principale
Trattamento
Allocazione
Randomizzato
Modello di intervento
In parallelo
Mascheramento
Singolo
Bracci / Interventi
Gruppo/Braccio di partecipantiIntervento/Trattamento
SperimentaleTherapy group A patients with Cystic Fibrosis
Participation on an online group cognitive behavioral psychotherapy via Zoom in 13 sessions.
Group a an Online Group Cognitive Behavioral Psychotherapy in 13 Sessions Via Zoom
An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy Group A, to patients with cystic fibrosis
Comparatore attivoControl group B Patients with cystic fibrosis
Participation on an online group supportive psychotherapy via Zoom in 13 sessions.
Group B an Online Group Supportive Psychotherapy in 13 Sessions Via Zoom
An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control group Group B, to patients with cystic fibrosis
SperimentaleTherapy group C caregivers of patients with cystic fibrosis
Participation on an online group cognitive behavioral psychotherapy via Zoom in 13 sessions.
Group C an Online Group Cognitive Behavioral Psychotherapy in 13 Sessions Via Zoom
An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy group C, to caregivers of patients with cystic fibrosis
Comparatore attivoContol group D caregivers of patients with cystic fibrosis
Participation on an online group supportive psychotherapy via Zoom in 13 sessions.
Group D an Online Group Supportive Psychotherapy in 13 Sessions Via Zoom
An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control Group D, to caregivers of patients with cystic fibrosis
Esito primario
Misure di esitoDescrizione della misuraArco temporale
SCL-90-R
It evaluates psychopathology. T\>60 means psychopathology. Low scores better
Preintervention
SCL-90-R
It evaluates psychopathology. T\>60 means psychopathology. Low scores better
Immediately after the intervention
SCL-90-R
It evaluates psychopathology. T\>60 means psychopathology. Low scores better
Follow-up up to 24 weeks
SRSDA
It measures Depression. Minimum 0 Maximum over 14. Low scores better
Preintervention
SRSDA
It measures Depression. Minimum 0 Maximum over 14. Low scores better
Immediately after intervention
SRSDA
It measures Depression. Minimum 0 Maximum over 14. Low scores better
Follow-up up to 24 weeks
SRSDA
It measures anxiety. Minimum 0 Maximum over 10. Low scores better
Preintervention
SRSDA
It measures anxiety. Minimum 0 Maximum over 10. Low scores better
Immediately after intervention
SRSDA
It measures anxiety. Minimum 0 Maximum over 10. Low scores better
Follow-up up to 24 weeks
U Uncertainty questionnaire
It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9)
Preintervention
U Uncertainty questionnaire
It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9)
Immediately after the intervention
U Uncertainty questionnaire
It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9)
Follow up up to 24 weeks
Hamilton Depression Scale
It measures depression. Minimum 0, maximum 23. Low scores better.
Preintervention
Hamilton Depression Scale
It measures depression. Minimum 0, maximum 23. Low scores better.
Immediately after the intervention
Hamilton Depression Scale
It measures depression. Minimum 0, maximum 23. Low scores better.
Follow up up to 24 weeks
WHODAS total
It measures functional outcome. Minimum 0, maximum 100. low scores better.
Preintervention
WHODAS total
It measures functional outcome. Minimum 0, maximum 100. low scores better.
Immediately after the intervention
WHODAS total
It measures functional outcome. Minimum 0, maximum 100. low scores better.
Follow up up to 24 weeks
RAS-DS total
Recovery. It measures recovery. Minimum 0, maximum 152. High scores better.
Preintervention
RAS-DS total
Recovery. It measures recovery. Minimum 0, maximum 152. High scores better.
Immediately after intervention
RAS-DS total
Recovery. It measures recovery. Minimum 0, maximum 152. High scores better.
Follow up up to 24 weeks
Criteri di eleggibilità

Età idonea
Adulto, Adulto anziano
Età minima
18 Years
Sessi idonei
Tutti
  • Age 18-70
  • Members of the Hellenic Cystic Fibrosis Association
  • Willingness to participate on 13 sessions via Zoom

  • Age over 70
  • Not members of the Hellenic Cystic Fibrosis Association
  • Not able to participate on 13 sessions via Zoom
Rakitzi, Stavroula logoRakitzi, Stavroula
Parte responsabile dello studio
Dr. Stavroula Rakitzi, Investigatore principale, PhD, Clinical psychologist and cognitive behavioral psychotherapist, Rakitzi, Stavroula
Contatti principali dello studio
Contatto: Dr. Stavroula Rakitzi, PhD, +306989766935, [email protected]
Contatto: Mrs Anna Spinou, President of the Hellenic Cystic Fibrosis Association, Msc, +306944255853, [email protected]
1 Centri dello studio in 1 paesi
Private practice, ILISION 34 15771 Athens Greece, Athens, 15771, Greece
Dr. Stavroula Rakitzi, PhD, Contatto, +306989766935, [email protected]
Mrs Anna Spinou, President of the Hellenic Cystic Fibrosis Association, Msc, Contatto, +306944255853, [email protected]
In arruolamento